We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Kronos Bio Inc | NASDAQ:KRON | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.04 | 1.00 | 1.04 | 1.04 | 1.02 | 1.04 | 79,181 | 22:30:02 |
|
|
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
||
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading
Symbol(s)
|
Name of each exchange
on which registered
|
||
|
|
|
Item 7.01 |
Regulation FD Disclosure.
|
Item 9.01 |
Financial Statements and Exhibits.
|
Exhibit No.
|
Description
|
|
104
|
The cover page of this report has been formatted in Inline XBRL.
|
KRONOS BIO, INC.
|
||
By:
|
/s/ Norbert Bischofberger
|
|
Norbert Bischofberger, Ph.D.
|
||
President and Chief Executive Officer
|
||
Dated: October 5, 2023
|
Name
|
Degree
|
Affiliation
|
email
|
Miguel Villalona-Calero
|
MD
|
City of Hope National Medical Center, California, USA
|
mvillalona@coh.org
|
Monica Mita
|
MD MDSc
|
Cedars-Sinai Cancer Institute, California, USA
|
monica.mita@cshs.org
|
Alain Mita
|
MD
|
Cedars-Sinai Cancer Institute, California, USA
|
alain.mita@cshs.org
|
Noah Federman
|
MD
|
UCLA Jonsson Comprehensive Cancer Center, California, USA
|
nfederman@mednet.ucla.edu
|
Drew Rasco
|
MD, FASCO
|
START – San Antonio, Texas, USA
|
drasco@startsa.com
|
David Spigel
|
MD
|
Sarah Cannon Research Institute at Tennessee Oncology PLLC, Tennessee, USA
|
david.spigel@sarahcannon.com
|
Jia Luo
|
MD
|
Dana-Farber Cancer Institute, Massachusetts USA
|
jia_luo@dfci.harvard.edu
|
Gregory M. Cote
|
MD PhD
|
Massachusetts General Hospital, Massachusetts USA
|
gcote@partners.org
|
Glenn J Hanna
|
MD
|
Dana-Farber Cancer Institute, Massachusetts USA
|
gjhanna@partners.org
|
Richard E. Cutler
|
PhD
|
Kronos Bio, California, USA
|
rcutler@kronosbio.com
|
Pavan Kumar
|
PhD
|
Kronos Bio, Massachusetts, USA
|
pavan.kumar@kronosbio.com
|
Crystal MacKenzie
|
BS
|
Kronos Bio, California USA
|
crystal.mackenzie@kronosbio.com
|
Charles Lin
|
PhD
|
Kronos Bio, California USA
|
charles.lin@kronosbio.com
|
Jorge F. DiMartino
|
MD PhD
|
Kronos Bio, California USA
|
jorge.dimartino@kronosbio.com
|
Elizabeth A Olek
|
DO, MPH
|
Kronos Bio, California USA
|
eolek@kronosbio.com
|
Brian Van Tine
|
MD PhD
|
Washington University in St. Louis, Missouri, USA
|
bvantine@wustl.edu
|
Document and Entity Information |
Oct. 05, 2023 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Oct. 05, 2023 |
Entity File Number | 001-39592 |
Entity Registrant Name | Kronos Bio, Inc. |
Entity Central Index Key | 0001741830 |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 82-1895605 |
Entity Address, Address Line One | 1300 So. El Camino Real |
Entity Address, Address Line Two | Suite 400 |
Entity Address, City or Town | San Mateo |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 94402 |
City Area Code | 650 |
Local Phone Number | 781-5200 |
Title of 12(b) Security | Common Stock, $0.001 par value per share |
Trading Symbol | KRON |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
1 Year Kronos Bio Chart |
1 Month Kronos Bio Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions